• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大孕早期和孕中期羊水试验(CEMAT)的细胞遗传学方面

Cytogenetic aspects of the Canadian early and mid-trimester amniotic fluid trial (CEMAT).

作者信息

Winsor E J, Tomkins D J, Kalousek D, Farrell S, Wyatt P, Fan Y S, Carter R, Wang H, Dallaire L, Eydoux P, Welch J P, Dawson A, Lin J C, Singer J, Johnson J, Wilson R D

机构信息

Department of Laboratory Medicine and Pathobiology, The Toronto Hospital, Eaton 3-301, 200 Elizabeth Street, Toronto, Ontario, Canada, M5G 2C4.

出版信息

Prenat Diagn. 1999 Jul;19(7):620-7. doi: 10.1002/(sici)1097-0223(199907)19:7<620::aid-pd599>3.0.co;2-e.

DOI:10.1002/(sici)1097-0223(199907)19:7<620::aid-pd599>3.0.co;2-e
PMID:10419609
Abstract

Cytogenetic results from a large multicentre randomized controlled study of 2108 amniotic fluids obtained at 11+0-12+6 weeks (EA) and 1999 fluids at 15+0-16+6 weeks (MA) were compared. There was no statistically significant difference in the rate of chromosome abnormalities (EA =1.9 per cent; MA=1.7 per cent) or level III mosaicism (EA=0.2 per cent; MA= 0.2 per cent) between the groups. Level I and Level II mosaicism occurred more frequently in MA. Maternal cell contamination was not significantly different between the groups, but maternal cells only were analysed from one bloody EA fluid. The number of repeat amniocenteses because of cytogenetic problems was 2.2 per cent in the EA group compared with only 0.3 per cent in the MA group. On average, culture of EA fluids required one day more than MA fluids. Although both culture success (97.7 per cent) and accuracy (99.8 per cent) were high for patients randomized to the EA group, routine amniocentesis prior to 13 weeks' gestation is not recommended for clinical reasons including an increased risk of fetal loss and talipes equinovarus.

摘要

对在孕11⁺⁰至12⁺⁶周获取的2108份羊水样本(早孕期组,EA)以及在孕15⁺⁰至16⁺⁶周获取的1999份羊水样本(中孕期组,MA)进行的一项大型多中心随机对照研究的细胞遗传学结果进行了比较。两组之间在染色体异常率(早孕期组 = 1.9%;中孕期组 = 1.7%)或III级嵌合体水平(早孕期组 = 0.2%;中孕期组 = 0.2%)方面无统计学显著差异。I级和II级嵌合体在中孕期组中出现得更为频繁。两组之间母血细胞污染无显著差异,但仅对一份血性早孕期羊水样本中的母细胞进行了分析。因细胞遗传学问题进行重复羊膜腔穿刺术的比例在早孕期组为2.2%,而在中孕期组仅为0.3%。平均而言,早孕期羊水样本的培养比中孕期羊水样本多需要一天时间。尽管随机分配到早孕期组的患者培养成功率(97.7%)和准确率(99.8%)都很高,但出于包括胎儿丢失风险增加和马蹄内翻足等临床原因,不建议在妊娠13周前进行常规羊膜腔穿刺术。

相似文献

1
Cytogenetic aspects of the Canadian early and mid-trimester amniotic fluid trial (CEMAT).加拿大孕早期和孕中期羊水试验(CEMAT)的细胞遗传学方面
Prenat Diagn. 1999 Jul;19(7):620-7. doi: 10.1002/(sici)1097-0223(199907)19:7<620::aid-pd599>3.0.co;2-e.
2
Technical factors in early amniocentesis predict adverse outcome. Results of the Canadian Early (EA) versus Mid-trimester (MA) Amniocentesis Trial.早期羊膜腔穿刺术的技术因素可预测不良结局。加拿大早期(EA)与中期(MA)羊膜腔穿刺术试验的结果。
Prenat Diagn. 1999 Aug;19(8):732-8. doi: 10.1002/(sici)1097-0223(199908)19:8<732::aid-pd624>3.0.co;2-n.
3
A study of early amniocentesis for prenatal cytogenetic diagnosis.一项关于早期羊膜穿刺术用于产前细胞遗传学诊断的研究。
Prenat Diagn. 1998 Jan;18(1):21-8.
4
Canadian multicenter randomized clinical trial of chorion villus sampling and amniocentesis. chromosome mosaicism in CVS and amniocentesis samples.加拿大绒毛取样和羊膜穿刺术多中心随机临床试验。绒毛取样和羊膜穿刺术样本中的染色体嵌合体。
Prenat Diagn. 1992 May;12(5):443-66. doi: 10.1002/pd.1970120514.
5
Cytogenetic analysis of 1375 amniotic fluid specimens from pregnancies with gestational age less than 14 weeks.对1375例孕周小于14周的妊娠羊水标本进行细胞遗传学分析。
Prenat Diagn. 1993 Sep;13(9):801-5. doi: 10.1002/pd.1970130903.
6
Amniocentesis before 14 completed weeks as an alternative to transabdominal chorionic villus sampling: a controlled trial with infant follow-up.孕14足周前羊膜腔穿刺术作为经腹绒毛取样的替代方法:一项对婴儿进行随访的对照试验。
Prenat Diagn. 1998 May;18(5):465-75.
7
Cytogenetic results from the U.S. Collaborative Study on CVS.美国绒毛取样协作研究的细胞遗传学结果。
Prenat Diagn. 1992 May;12(5):317-45. doi: 10.1002/pd.1970120503.
8
Clinical significance of amniotic-fluid-cell culture failure.
Prenat Diagn. 1998 Apr;18(4):343-7.
9
Early amniocentesis: effect of removing a reduced volume of amniotic fluid on pregnancy outcome.早期羊膜腔穿刺术:抽取减少量羊水对妊娠结局的影响。
Prenat Diagn. 1998 Aug;18(8):773-8. doi: 10.1002/(sici)1097-0223(199808)18:8<773::aid-pd350>3.0.co;2-w.
10
Early amniocentesis--a cytogenetic evaluation of over 1500 cases.早期羊膜穿刺术——1500多例的细胞遗传学评估。
Prenat Diagn. 1994 Jun;14(6):497-501. doi: 10.1002/pd.1970140615.

引用本文的文献

1
Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (2) Invasive Diagnostic Testing for Fetal Chromosomal Abnormalities.韩国母胎医学会产前非整倍体筛查和诊断检测临床实践指南:(2)胎儿染色体异常的有创性诊断检测。
J Korean Med Sci. 2021 Jan 25;36(4):e26. doi: 10.3346/jkms.2021.36.e26.
2
Concordance between different trophectoderm biopsy sites and the inner cell mass of chromosomal composition measured with a next-generation sequencing platform.不同滋养层活检部位与下一代测序平台测量的内细胞团的染色体组成的一致性。
Mol Hum Reprod. 2018 Dec 1;24(12):593-601. doi: 10.1093/molehr/gay043.
3
Amniocentesis and chorionic villus sampling for prenatal diagnosis.
用于产前诊断的羊膜穿刺术和绒毛取样。
Cochrane Database Syst Rev. 2017 Sep 4;9(9):CD003252. doi: 10.1002/14651858.CD003252.pub2.
4
NSGC practice guideline: prenatal screening and diagnostic testing options for chromosome aneuploidy.美国医学遗传学与基因组学学会实践指南:染色体非整倍体的产前筛查和诊断检测选项
J Genet Couns. 2013 Feb;22(1):4-15. doi: 10.1007/s10897-012-9545-3. Epub 2012 Nov 22.
5
Amniocentesis and chorionic villus sampling for prenatal diagnosis.用于产前诊断的羊膜穿刺术和绒毛取样。
Cochrane Database Syst Rev. 2003(3):CD003252. doi: 10.1002/14651858.CD003252.